Table 1.
Comparison of baseline data between the two groups
Clinical features | Group | p | ||
---|---|---|---|---|
|
|
|||
Characteristic | Category | CG (n=30) | OG (n=30) | |
Gender | Male | 21 | 22 | 0.658 |
Female | 9 | 8 | ||
Age (yrs) | 60.4±5.33 | 60.7±4.71 | 0.865 | |
Lesion morphology | Protruded type | 11 | 12 | 0.756 |
Ulcerative type | 12 | 11 | ||
Infiltrative type | 7 | 7 | ||
KRAS gene mutation | KRAS-wild | 21 | 22 | 0.867 |
KRAS-mutant | 9 | 8 |
CG: control group; OG: observation group; KRAS: Kirsten rat sarcoma viral oncogene.